Abbott And Alza Will Discuss Ditropan XL Copromotion In Merger Post-Mortem
Executive Summary
Abbott and Alza are discussing whether the five-year copromotion agreement for Alza's Ditropan XL (oxybutynin) will survive the Dec. 16 collapse of the pending merger.